Quantcast

Latest Rickets Stories

2008-10-14 00:00:03

By The Associated Press CHICAGO (AP) - The nation's leading pediatricians group says children from newborns to teens should get double the usually recommended amount of vitamin D because of evidence that it might help prevent serious diseases. To meet the new recommendation of 400 units daily, millions of children will need to take daily vitamin D supplements, the American Academy of Pediatrics said. That includes breast-fed infants - even those who get some formula, too, and many teens...

a45897efb906f11905677d41a33f75d81
2008-10-13 12:05:00

Newborns and teenagers should receive twice the recommended amount of Vitamin D due to evidence that shows it may help prevent serious diseases, a leading pediatricians group reported Monday. According to the American Academy of Pediatrics, newborns and teenagers should consumer 400 units each day. Millions of kids will need to take daily vitamin D supplements "“ including those who get some formula, too, and many teens who drink little or no milk at all. Infants who drink formula...

2008-10-13 09:00:05

By LINDSEY TANNER By Lindsey Tanner The Associated Press CHICAGO The nation's leading pediatricians group says children from newborns to teens should get double the usually recommended amount of vitamin D because of evidence that it may help prevent serious diseases. To meet the new recommendation of 400 units daily, millions of children will need to take daily vitamin D supplements, the American Academy of Pediatrics said. That includes breast-fed infants - even those who get some...

2008-09-22 09:00:12

MONTREAL, Sept. 22 /PRNewswire/ -- Enobia Pharma, a biotech company focused on developing novel therapeutics for serious bone disorders, today announced key appointments to add commercial and manufacturing expertise to the Company's senior management team in conjunction with the recent initiation of two clinical trials of ENB-0040 for the treatment of hypophosphatasia. Julie Anne Smith has been appointed as Enobia's Vice President, Chief Commercial Officer, and Jayant Aphale, PhD., MBA has...

2008-09-19 12:00:10

MONTREAL, Sept. 19 /PRNewswire/ -- Enobia Pharma, an emerging biotech company focused on developing novel therapeutics for serious bone disorders, announced that it has received Orphan Drug designation from the U.S. Food and Drug Administration (FDA) for ENB-0040, its enzyme replacement therapy (ERT) for hypophosphatasia, a rare, life-threatening genetic bone disease. In August 2008, Enobia dosed the first patient in a Phase I clinical trial of ENB-0040. "ENB-0040 represents a potential...

2008-09-15 15:00:09

MONTREAL, Sept. 15 /PRNewswire/ -- Enobia Pharma, an emerging biotech company focused on developing novel therapeutics for serious bone disorders, presented pre-clinical data demonstrating that its enzyme replacement therapy (ERT) for hypophosphatasia appears to heal bones that have already been severely weakened by the disease. Earlier pre-clinical data showed that ERT with Enobia's product ENB-0040, significantly increases survival and prevents bone hypomineralization associated with...

2008-09-05 03:00:06

By Mark, Sean Gray-Donald, Katherine; Delvin, Edgard E; O'Loughlin, Jennifer; Paradis, Gilles; Levy, Emile; Lambert, Marie BACKGROUND: Adequate vitamin D status is important for bone growth and mineralization and has been implicated in the regulation of autoimmunity, metabolic function, and cancer prevention. There are no reports of population-based studies on the vitamin D status of Canadian youth, a population with mandatory fortification of foods. METHODS: We measured plasma...

2008-08-22 03:00:10

By Skowron, Jared M Myth 1: Vitamin D is a vitamin. The Truth: Vitamin D is a hormone. It's derived from cholesterol. It activates cellular processes and does not do so as a co-factor. Vitamin D receptors nave direct effects on the following cells: adipose, adrenal, bone, brain, breast, cancer, cartilage, colon, endothelium, epididymis, ganglion, hair follicle, intestine, kidney, liver, lung, muscle, osteoblasts, ovary, pancreatic B, parathyroid, parotid, pituitary, placenta, prostate,...

2008-08-20 15:00:19

MONTREAL, Aug. 20 /PRNewswire/ -- Enobia Pharma, an emerging biotech company focused on developing novel therapeutics for serious bone disorders, today announced that the first patient in its clinical program for hypophosphatasia has been dosed. Enobia is investigating Enzyme Replacement Therapy (ERT) with ENB-0040 for the treatment of this rare and often crippling genetic bone disorder for which there is no approved treatment. Under two separate protocols, ENB-0040 will be evaluated in...

2008-08-01 21:00:08

NEW YORK, Aug. 1 /PRNewswire/ -- Even if your child is one of the millions who doesn't get enough calcium in their diet, a new study shows it's not too late to increase bone density. The study published in the August issue of 'Bone', found increasing dietary calcium in the diet has a significant impact on bone development. The Huncharek study, funded by the National Dairy Council to help generate awareness of the importance of calcium, assessed data from 21 randomized clinical trials with...


Word of the Day
caparison
  • A cloth or covering, more or less ornamented, laid over the saddle or furniture of a horse, especially of a sumpter-horse or horse of state.
  • Clothing, especially sumptuous clothing; equipment; outfit.
  • To cover with a caparison, as a horse.
  • To dress sumptuously; adorn with rich dress.
This word ultimately comes from the Medieval Latin 'cappa,' cloak.
Related